Search
Regeneron Pharmaceuticals Inc
REGNAdd to Watchlist
609.940USD
+2.010+0.33%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
64.47BMarket Cap
14.36P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Sanofi
5.88B
41.02%
EYLEA
2.75B
19.16%
EYLEA HD
1.64B
11.41%
Bayer
1.42B
9.92%
Libtayo
944.70M
6.59%
Other
1.71B
11.90%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Sanofi
5.88B
41.02%
EYLEA
2.75B
19.16%
EYLEA HD
1.64B
11.41%
Bayer
1.42B
9.92%
Libtayo
944.70M
6.59%
Other
1.71B
11.90%
